Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$373,959
New position
Shares Held
6,873
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#487
of 754 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026BTG Pactual Asset Management US LLC holds $6,060,072 across 7 Biotechnology names. EXEL ranks #2 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
70,732 | $3,965,943 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
6,873 | $373,959 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
591 | $368,512 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
1,123 | $354,969 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,454 | $350,370 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
4,164 | $325,916 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
1,309 | $320,403 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $373,959 | 6,873 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||